Norway· NO-ID_42892529-B3DF-438C-B136-9D36AE7BA651
Filspari
A sparsentan product containing sparsentan, registered in Norway by Vifor France. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Sparsentan is registered in 10 of 19 countries.
Countries holding a registration under ATC C09XX01 (sparsentan), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Sparsentan · ATC C09XX01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Sparsentan
- Manufacturer
- Vifor France
- Country
- Norway (NO)
- ATC code
- C09XX01
- ATC class
- Sparsentan
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_42892529-B3DF-438C-B136-9D36AE7BA651
- no_varenummer48787230NOK 60143.8
- gtin3665456000027
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sparsentan in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFILSPARIVifor France, Paris
- SwitzerlandFilspari 400 mg, FilmtablettenVifor (International) Inc.
- FinlandFILSPARIVifor France
- IrelandFilspari 400 mg film-coated tabletsVifor France
- IcelandFilspariVifor France
- NetherlandsFilspari 400 mg filmomhulde tablettenVifor France
- PolandFilspariVifor France
- SwedenFilspari 400 mg Filmdragerad tablettVifor France SA
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Filspari
- Liechtenstein · Filspari
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d113e840-0350-415a-9833-ea462d03bf04 GET /v1/drugs/d113e840-0350-415a-9833-ea462d03bf04?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Sparsentan",
"merkevare_id": "ID_42892529-B3DF-438C-B136-9D36AE7BA651",
"name_form_strength": "Filspari tab 400 mg",
"prescription_group": "C"
}See everything about sparsentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.